With CpGf-AFP-sr39 transfection, there was also significant cell death in AFP-producing HCC cells, with 26 ± 1% and 15 ± 2% viability on day 9 in Hep3b and Huh7 cells, respectively. This evidence concerns the gene AFP and hepatocellular carcinoma.